How much time does it take to prescribe a new medication?

Patient Education and Counseling
Derjung M TarnNeil S Wenger

Abstract

To measure the length of time spent discussing all aspects of new prescriptions and guideline-recommended aspects of counseling, and to evaluate factors associated with duration of discussion. We analyzed tape recordings in which 181 patients received 234 new medication prescriptions from 16 family physicians, 18 internists, and 11 cardiologists in 2 healthcare systems in Sacramento, California between January and November 1999. Of the mean total visit time of 15.9min (S.D.=434s), a mean of 26s (S.D.=28s) was allocated to guideline-recommended components and a mean of 23s (S.D.=25s) was allocated to discussion of all other aspects of new prescription medications. The majority of time spent discussing individual new prescriptions was dedicated to: medication purpose or justification, directions and duration of use, and side effects. On average, more complete discussion of these components was associated with more time. More time was spent talking about guideline-recommended information if patients were in better health, if there was a third party in the room, and if the medication belonged to a psychiatric, compared to an ear, nose, throat medication class. Less time was spent discussing over-the-counter (OTC) medications and th...Continue Reading

References

Jan 25, 1992·BMJ : British Medical Journal·A WilsonJ Cooney
Mar 29, 1986·British Medical Journal·M O RolandD C Morrell
Feb 5, 1999·Archives of Family Medicine·R S StaffordD Blumenthal
May 10, 1985·Patient Education and Counseling·L ScherwitzC Vallbona
Dec 28, 1999·JAMA : the Journal of the American Medical Association·C H BraddockW Levinson
Mar 1, 2000·Social Science & Medicine·F A StevensonC P Bradley
Feb 15, 2001·The New England Journal of Medicine·D MechanicM Rosenthal
Sep 15, 2001·The New England Journal of Medicine·E P Brass
Oct 17, 2001·Annals of Internal Medicine·E L Knight, J Avorn
Dec 19, 2001·Medical Care·Richard L KravitzDavid Thom
Apr 16, 2002·BMJ : British Medical Journal·George K FreemanAndrew Wilson
Aug 10, 2002·JAMA : the Journal of the American Medical Association·Debra L RoterYutaka Aoki
Aug 31, 2002·BMJ : British Medical Journal·Myriam DeveugeleJan De Maeseneer
Mar 28, 2003·American Journal of Public Health·Kimberly S H YarnallJ Lloyd Michener
Aug 21, 2003·JAMA : the Journal of the American Medical Association·G Caleb AlexanderDavid O Meltzer
Jun 24, 2004·Annals of Family Medicine·Chih-Wen ShiMichael B Nichol
Jul 10, 2004·Journal of General Internal Medicine·G Caleb AlexanderDavid O Meltzer
Oct 28, 2004·Annals of Family Medicine·John W BeasleyJames Bobula
Aug 10, 2005·Archives of Internal Medicine·John D PietteEve A Kerr
Jan 27, 2006·The Cochrane Database of Systematic Reviews·A D Wilson, S Childs
Jun 20, 2006·Patient Education and Counseling·Claude Richard, Marie-Thérèse Lussier
Sep 27, 2006·Archives of Internal Medicine·Derjung M TarnNeil S Wenger
Mar 16, 2007·Journal of General Internal Medicine·Ming Tai-SealeXiaoming Bao
Sep 14, 2007·Health Services Research·Ming Tai-SealeWeimin Zhang
Oct 4, 2007·Journal of the American Geriatrics Society·William H ShrankJerry Avorn

❮ Previous
Next ❯

Citations

Oct 14, 2011·Medical Care·Leah S KarlinerKarla Kerlikowske
Jul 22, 2010·Journal of the Medical Library Association : JMLA·Marianne BurkeFred Pond
Nov 5, 2013·Patient Education and Counseling·Christy J W LedfordHeather D Mundy
Aug 21, 2013·European Journal of Public Health·Kathryn HoffmannManfred Maier
Dec 2, 2008·The Journal of Dermatological Treatment·Andreas StormJørgen Andersen
May 16, 2009·Journal of the American Pharmacists Association : JAPhA·Michelle A ChuiJennifer M Peng
Jul 22, 2014·Pain Medicine : the Official Journal of the American Academy of Pain Medicine·Danielle M McCarthyMike S Wolf
Feb 26, 2016·Research in Social & Administrative Pharmacy : RSAP·Marie A SmithBrody McConnell
Aug 28, 2012·Revista Española De Cardiología·Valentín Fuster
Oct 8, 2013·World Psychiatry : Official Journal of the World Psychiatric Association (WPA)·John M KaneChristoph U Correll
May 11, 2011·Health Services Research·Urmimala SarkarRalph Gonzales
Oct 30, 2013·The International Journal of Pharmacy Practice·Olufunmilola K OdukoyaJia Pu
Sep 2, 2015·Health Communication·Heather M Traino, Laura A Siminoff
Nov 3, 2010·Patient Education and Counseling·Urmimala SarkarEliseo J Pérez-Stable
Jul 4, 2015·Journal of Graduate Medical Education·Christy J W LedfordHeather D Mundy
Aug 20, 2014·Journal of Patient Safety·Daniel DarbyshireSteven Agius
Mar 4, 2014·Journal of Patient Safety·Sarah A GertlerUrmimala Sarkar
Nov 6, 2013·Health Affairs·Marie SmithThomas S Bodenheimer
Oct 13, 2017·The Annals of Pharmacotherapy·Marie A Smith
Jan 17, 2020·Ocular Immunology and Inflammation·Hedayat JavidiPhilip I Murray
Feb 20, 2020·Journal of Cutaneous Medicine and Surgery·Valérie Johnson GirardMarie-Thérèse Lussier
Feb 15, 2020·Healthcare Management Forum·Martin Dawes
Jun 30, 2018·The Mental Health Clinician·Michelle D ColvardAmy VandenBerg
Oct 18, 2019·Therapeutic Advances in Drug Safety·Françoise Livio, Catia Marzolini
Sep 1, 2013·Global Heart·Jose M CastellanoValentin Fuster
Mar 11, 2020·BMC Endocrine Disorders·Julius Chacha MwitaTonya M Esterhuizen
Jan 1, 2017·Expert Review of Precision Medicine and Drug Development·Susanne B Haga

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.